...
首页> 外文期刊>Clinical practice and epidemiology in mental health >Combining an SSRI with an anticonvulsant in depressed patients with dysphoric mood: an open study
【24h】

Combining an SSRI with an anticonvulsant in depressed patients with dysphoric mood: an open study

机译:在情绪低落的抑郁症患者中将SSRI与抗惊厥药联合使用:一项开放研究

获取原文
           

摘要

Background Several patients with unipolar depression present with prominent dysphoric mood. We aimed at examining the effectiveness of the combination of an SSRI with an anticonvulsant in such patients. Methods Thirty-five newly admitted outpatients with substantial anger, irritability, aggressiveness or hostility who were diagnosed a DSM-IV unipolar depressive disorder were rated on the Hamilton Depression Rating Scale (HDRS), the Clinical Global Improvement (CGI) scale, and a scale for the rapid dimensional assessment (SVARAD), were prescribed an SSRI and an anticonvulsant (usually valproate), and were followed up for 12 weeks. Repeated measures analysis of variance was used to test for within-subject changes in scale scores over time. Results Thirty-two and 23 patients attended the follow-up visits 4 and 12 weeks later, respectively. Significant decreases (p < .001) were observed in HDRS total score, HDRS and SVARAD anxiety factors, HDRS and SVARAD core depression factors, and SVARAD anger/irritability factor. Adjusting for age or gender did not change the results. Most patients (82%) were rated as improved or much improved on the CGI. Conclusion Although our study has several limitations, we observed a remarkable improvement in most unipolar depressed outpatients with dysphoric mood treated with an SSRI and an anticonvulsant. The effectiveness of anticonvulsants might be linked to their action on symptoms of aggression and behavioural activation.
机译:背景几位单相抑郁症患者表现出明显的烦躁情绪。我们旨在检查SSRI与抗惊厥药联合治疗此类患者的有效性。方法采用汉密尔顿抑郁量表(HDRS),临床总体改善量表(CGI)和量表对35位新近被诊断为DSM-IV单相抑郁症的愤怒,易怒,攻击性或敌意的新入院患者进行评估为了进行快速尺寸评估(SVARAD),开了SSRI和抗惊厥药(通常是丙戊酸盐),并随访了12周。重复测量方差分析用于检验受试者得分随时间的变化。结果分别在4周和12周后对32例患者和23例患者进行了随访。在HDRS总分,HDRS和SVARAD焦虑因素,HDRS和SVARAD核心抑郁因素以及SVARAD愤怒/易怒因素中,观察到显着降低(p <.001)。调整年龄或性别不会改变结果。大多数患者(82%)的CGI评分为改善或大大改善。结论尽管我们的研究有一些局限性,但我们观察到在大多数单极性抑郁门诊患者中,使用SSRI和抗惊厥药治疗的烦躁情绪明显改善。抗惊厥药的有效性可能与其对侵略和行为激活症状的作用有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号